Why the study?
Does Multiplate impedance platelet aggregometry correlate with light transmission aggregometry and PFA-100 for assessing residual platelet reactivity in ACS patients on dual antiplatelet therapy?
Does Multiplate impedance platelet aggregometry correlate with light transmission aggregometry and PFA-100 for assessing residual platelet reactivity in ACS patients on dual antiplatelet therapy?
Answers are grounded in this paper and cite their sources.
Multiplate impedance platelet aggregometry correlates well with standard methods like LTA and PFA-100, offering a reliable and rapid tool for monitoring antiplatelet therapy in clinical practice.
This study sought to compare Multiplate impedance platelet aggregometry (IPA) with light transmission aggregometry (LTA) and the PFA-100 for determining the prevalence of residual platelet reactivity (RPR) by the Multiplate IPA in 297 patients with acute coronary syndrome receiving dual antiplatelet therapy. Aggregations were induced by adenosine-5 diphosphate (ADP), arachidonic acid, and collagen. PFA-100 closure times were measured by collagen and ADP and epinephrine (CEPI) cartridges. Significant correlations were observed between Multiplate IPA and LTA after all stimulations (P < .0001) and between Multiplate IPA (arachidonate and collagen) and PFA-100 CEPI closure time (P < .0001 for both). Cutoff values of Multiplate IPA (for all stimulations) were calculated for the identification of RPR. Between the Multiplate IPA and LTA good agreement was found with all 3 agonists (P < .0001 for all). Multiplate IPA might represent a reliable, handy, rapid tool to monitor antiplatelet therapy in clinical practice and for clinical investigations.
No takes yet. Share an insight, caveat, or question.
Paniccia et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: